Combination of co-amorphization with SNEDDS outperforms Ofev® in the oral absorption of nintedanib

T Inoue, S Maehara, M Maruyama, K Higaki - International Journal of …, 2024 - Elsevier
Nintedanib (NTD), approved for the treatment of idiopathic pulmonary fibrosis and advanced
non-small cell lung cancer, is one of brick dusts with high melting point. Although NTD has …